Tang YM[au] - Search Results

Year	Number of Results
1986	2
1990	1
1991	1
1992	2
1994	1
1996	4
1997	1
1998	7
1999	6
2000	2
2002	4
2003	5
2004	9
2005	14
2006	11
2007	15
2008	8
2009	4
2010	10
2011	14
2012	18
2013	19
2014	14
2015	11
2016	23
2017	20
2018	11
2019	18
2020	14
2021	25
2022	29
2023	7

1

A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.

Gui CP, Wei JH, Chen YH, Fu LM, Tang YM, Cao JZ, Chen W, Luo JH. Gui CP, et al. Among authors: tang ym. Brief Bioinform. 2021 Nov 5;22(6):bbab173. doi: 10.1093/bib/bbab173. Brief Bioinform. 2021. PMID: 34237133

2

Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer.

Gui CP, Li JY, Fu LM, Luo CG, Zhang C, Tang YM, Zhang LZ, Shu GN, Wu RP, Luo JH. Gui CP, et al. Among authors: tang ym. J Big Data. 2022;9(1):88. doi: 10.1186/s40537-022-00641-z. Epub 2022 Jul 7. J Big Data. 2022. PMID: 35818395 Free PMC article.

3

circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.

Gui CP, Liao B, Luo CG, Chen YH, Tan L, Tang YM, Li JY, Hou Y, Song HD, Lin HS, Xu QH, Yao GS, Yao HH, Xi-Liu, Luo JH, Cao JZ, Wei JH. Gui CP, et al. Among authors: tang ym. Mol Cancer. 2021 Dec 18;20(1):169. doi: 10.1186/s12943-021-01449-w. Mol Cancer. 2021. PMID: 34922539 Free PMC article.

4

Gout in China, 1990-2017: the Global Burden of Disease Study 2017.

Tang YM, Zhang L, Zhu SZ, Pan JJ, Zhou SH, He TJ, Li Q. Tang YM, et al. Public Health. 2021 Feb;191:33-38. doi: 10.1016/j.puhe.2020.06.029. Epub 2021 Jan 19. Public Health. 2021. PMID: 33482625

5

Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis.

Zhang MX, Zhang LZ, Fu LM, Yao HH, Tan L, Feng ZH, Li JY, Lu J, Pan YH, Shu GN, Li PJ, Tang YM, Liao ZY, Wei JH, Chen W, Guo JP, Luo JH, Chen ZH. Zhang MX, et al. Among authors: tang ym. Oncogene. 2021 Sep;40(37):5639-5650. doi: 10.1038/s41388-021-01971-7. Epub 2021 Jul 28. Oncogene. 2021. PMID: 34321604 Free PMC article.

6

Treatment of a recurrent rectal anastomotic stenosis.

Tang YM, Fan Y. Tang YM, et al. ANZ J Surg. 2022 Sep;92(9):2397-2398. doi: 10.1111/ans.17951. ANZ J Surg. 2022. PMID: 36097425 No abstract available.

7

[Advances in Structural Designs of Chimeric Antigen Receptor T Cells--Review].

Ying PT, Weng WW, Tang YM. Ying PT, et al. Among authors: tang ym. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Dec;30(6):1902-1906. doi: 10.19746/j.cnki.issn.1009-2137.2022.06.043. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36476923 Review. Chinese.

8

Advances in the pharmacological activities and mechanisms of diosgenin.

Chen Y, Tang YM, Yu SL, Han YW, Kou JP, Liu BL, Yu BY. Chen Y, et al. Among authors: tang ym. Chin J Nat Med. 2015 Aug;13(8):578-87. doi: 10.1016/S1875-5364(15)30053-4. Chin J Nat Med. 2015. PMID: 26253490 Review.

9

Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children.

Xu XJ, Tang YM. Xu XJ, et al. Among authors: tang ym. World J Pediatr. 2020 Aug;16(4):333-340. doi: 10.1007/s12519-019-00299-3. Epub 2019 Sep 10. World J Pediatr. 2020. PMID: 31506890 Review.

10

MRI features of bone marrow necrosis.

Tang YM, Jeavons S, Stuckey S, Middleton H, Gill D. Tang YM, et al. AJR Am J Roentgenol. 2007 Feb;188(2):509-14. doi: 10.2214/AJR.05.0656. AJR Am J Roentgenol. 2007. PMID: 17242262 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results